Chemfab Alkalis Ltd. (IN:CHEMFAB)
:CHEMFAB
Top Page
Chemfab Alkalis Ltd.
(CHEMFAB)
Select Model
Select Model
Rating:59Neutral
Price Target:
₹337.00
▼(-20.88% Downside)
Action:ReiteratedDate:04/02/26
Moderate score driven by solid balance sheet strength and improved cash flow, partially offset by negative net income. Technicals are a major headwind with a sustained downtrend (price below all key moving averages) and negative momentum indicators; valuation support is limited due to a loss-making P/E and low dividend yield.
Positive Factors
Balance Sheet Strength
A healthy equity ratio and low debt-to-equity indicate low financial risk and greater resilience to cyclical swings. This durable capital structure supports funding for working capital, modest capex, and optionality on financing decisions over the next 2–6 months.
Negative Factors
Negative Net Income
Reported negative net income erodes retained earnings and reduces internal equity cushions. Even with improving cash metrics, recurring accounting losses can constrain long-term reinvestment, investor confidence, and may necessitate strategic corrective measures.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance Sheet Strength
A healthy equity ratio and low debt-to-equity indicate low financial risk and greater resilience to cyclical swings. This durable capital structure supports funding for working capital, modest capex, and optionality on financing decisions over the next 2–6 months.
Read all positive factors
Chemfab Alkalis Ltd. (CHEMFAB) vs. iShares MSCI India ETF (INDA)
Market Cap
₹5.32B
Dividend Yield0.28%
Average Volume (3M)1.01K
Price to Earnings (P/E)―
Beta (1Y)1.15
Revenue Growth5.19%
EPS Growth-152.09%
CountryIN
Employees210
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)-3.09
Shares Outstanding14,373,702
10 Day Avg. Volume463
30 Day Avg. Volume1,011
Financial Highlights & Ratios
PEG Ratio1.21
Price to Book (P/B)2.79
Price to Sales (P/S)3.18
P/FCF Ratio26.61
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Chemfab Alkalis Ltd. Business Overview & Revenue Model
Company Description
Chemfab Alkalis Limited manufactures and sells inorganic chemicals in India and internationally. It operates through Chemicals and Related Products/Services, and PVC-O Pipes segments. It offers caustic soda lye and flakes, liquid chlorine, hydroge...
How the Company Makes Money
null...
Chemfab Alkalis Ltd. Financial Statement Overview
Summary
Income Statement
65
Positive
Balance Sheet
70
Positive
Cash Flow
75
Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.44B | 3.34B | 3.27B | 3.31B | 2.71B | 1.81B |
| Gross Profit | 1.16B | 1.16B | 573.09M | 1.57B | 972.61M | 604.57M |
| EBITDA | 461.50M | 444.34M | 632.53M | 1.13B | 624.45M | 250.16M |
| Net Income | -67.65M | -69.40M | 263.23M | 645.83M | 287.47M | -81.31M |
Balance Sheet | ||||||
| Total Assets | 5.67B | 5.22B | 5.00B | 4.12B | 3.52B | 3.35B |
| Cash, Cash Equivalents and Short-Term Investments | 12.04M | 211.84M | 76.98M | 692.16M | 328.37M | 266.44M |
| Total Debt | 1.09B | 843.41M | 201.11M | 23.57M | 86.47M | 315.46M |
| Total Liabilities | 1.88B | 1.42B | 1.13B | 507.42M | 541.82M | 676.00M |
| Stockholders Equity | 3.79B | 3.80B | 3.87B | 3.61B | 2.98B | 2.67B |
Cash Flow | ||||||
| Free Cash Flow | -652.58M | 399.09M | -605.69M | 349.82M | 347.13M | 380.96M |
| Operating Cash Flow | 112.34M | 399.09M | 313.54M | 925.95M | 549.10M | 454.32M |
| Investing Cash Flow | -511.78M | -859.86M | -1.10B | -475.12M | -210.25M | -64.33M |
| Financing Cash Flow | 204.85M | 587.23M | 160.65M | -88.92M | -245.73M | -155.91M |
Chemfab Alkalis Ltd. Technical Analysis
Neutral
425.95
Price Trends
377.36
Negative
422.05
Negative
550.99
Negative
Market Momentum
-13.17
Negative
52.04
Neutral
77.03
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:CHEMFAB, the sentiment is Neutral. The current price of 425.95 is above the 20-day moving average (MA) of 352.68, above the 50-day MA of 377.36, and below the 200-day MA of 550.99, indicating a neutral trend. The MACD of -13.17 indicates Negative momentum. The RSI at 52.04 is Neutral, neither overbought nor oversold. The STOCH value of 77.03 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:CHEMFAB.
Chemfab Alkalis Ltd. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | ₹7.92B | 11.95 | ― | 1.14% | 8.27% | 195.27% | |
62 Neutral | ₹11.27B | 17.66 | ― | 0.52% | 28.67% | 50.12% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ₹9.32B | 22.24 | ― | 1.23% | 0.69% | -7.54% | |
60 Neutral | ₹7.17B | 10.26 | ― | 0.81% | -4.92% | 1.29% | |
59 Neutral | ₹5.32B | -33.35 | ― | 0.28% | 5.19% | -152.09% | |
57 Neutral | ₹8.47B | 3.95 | ― | 0.82% | -2.41% | 178.19% |
* Basic Materials Sector Average
IN:CHEMFAB
Chemfab Alkalis Ltd.
370.15
-454.08
-55.09%
IN:JAYAGROGN
Jayant Agro-Organics Limited
193.45
-20.70
-9.67%
IN:KOTHARIPET
Kothari Petrochemicals Ltd.
121.83
-39.28
-24.38%
IN:MANALIPETC
Manali Petrochemicals Limited
49.23
-4.30
-8.03%
IN:SHREEPUSHK
Shree Pushkar Chemicals & Fertilisers Ltd.
348.60
117.72
50.99%
IN:TNPETRO
Tamilnadu Petro Products Ltd.
88.02
16.74
23.48%
Chemfab Alkalis Ltd. Corporate Events
Chemfab Alkalis Publishes Q3 FY26 Investor Presentation for Stakeholders
Jan 28, 2026
Chemfab Alkalis Limited has submitted and published an investor presentation for the quarter ended December 31, 2025, as a voluntary disclosure to stock exchanges and on its website, aiming to provide shareholders and market participants with upda...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.